Newron Pharmaceuticals S.p.A. (SWX:NWRN)
Switzerland flag Switzerland · Delayed Price · Currency is CHF
6.69
+0.15 (2.29%)
Apr 4, 2025, 11:30 AM CET

Newron Pharmaceuticals Income Statement

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Operating Revenue
51.396.795.955.765.26
Upgrade
Other Revenue
-2.260.14--
Upgrade
Revenue
51.399.066.095.765.26
Upgrade
Revenue Growth (YoY)
467.41%48.62%5.76%9.59%-25.29%
Upgrade
Gross Profit
51.399.066.095.765.26
Upgrade
Selling, General & Admin
-7.537.397.398.47
Upgrade
Research & Development
13.6413.1512.0110.7314.85
Upgrade
Other Operating Expenses
24.11----
Upgrade
Operating Expenses
37.7520.6919.418.1223.32
Upgrade
Operating Income
13.64-11.63-13.3-12.36-18.07
Upgrade
Interest Expense
-4.78-4.17-3.95-2.92-2.24
Upgrade
Interest & Investment Income
-0.180.060.050.06
Upgrade
Currency Exchange Gain (Loss)
--0.070.120.2-0.17
Upgrade
Other Non Operating Income (Expenses)
6.98-0.51-0.40.130.79
Upgrade
EBT Excluding Unusual Items
15.84-16.2-17.47-14.88-19.62
Upgrade
Pretax Income
15.84-16.2-17.47-14.88-19.62
Upgrade
Income Tax Expense
-0.020.020.021.38
Upgrade
Net Income
15.84-16.22-17.49-14.9-21
Upgrade
Net Income to Common
15.84-16.22-17.49-14.9-21
Upgrade
Shares Outstanding (Basic)
1918181818
Upgrade
Shares Outstanding (Diluted)
1918181818
Upgrade
Shares Change (YoY)
4.45%----
Upgrade
EPS (Basic)
0.85-0.91-0.98-0.84-1.18
Upgrade
EPS (Diluted)
0.85-0.91-0.98-0.84-1.18
Upgrade
Free Cash Flow
--10.15-11.11-11.47-15.62
Upgrade
Free Cash Flow Per Share
--0.57-0.62-0.64-0.88
Upgrade
Gross Margin
100.00%100.00%100.00%100.00%100.00%
Upgrade
Operating Margin
26.55%-128.40%-218.28%-214.46%-343.59%
Upgrade
Profit Margin
30.83%-179.13%-287.05%-258.61%-399.35%
Upgrade
Free Cash Flow Margin
--112.08%-182.31%-198.98%-297.11%
Upgrade
EBITDA
13.78-11.49-13.27-12.31-17.99
Upgrade
EBITDA Margin
26.81%-126.89%-217.67%-213.64%-
Upgrade
D&A For EBITDA
0.140.140.040.050.07
Upgrade
EBIT
13.64-11.63-13.3-12.36-18.07
Upgrade
EBIT Margin
26.55%-128.40%-218.28%-214.46%-
Upgrade
Revenue as Reported
51.399.066.095.765.26
Upgrade
Updated Sep 19, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.